Skip to main content

Vigabatrin News

FDA Approves Vigafyde (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution

PARSIPPANY, N.J.--(BUSINESS WIRE) June 17, 2024 --Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced...

FDA Medwatch Alert: InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets

December 09, 2023 – Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Epilepsy, Seizure Prevention, Seizure Prophylaxis, Seizures

Vigabatrin patient information at Drugs.com